⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ERNA News
Ernexa Therapeutics Inc. Common Stock
Ernexa Therapeutics Unveils Breakthrough Preclinical Results: ERNA-101 Achieves 100% Survival and Complete Tumor Elimination in Ovarian Cancer Models
globenewswire.com
ERNA
Form 8-K
sec.gov
ERNA
ERNAW
Ernexa Therapeutics Announces 1-for-25 Reverse Stock Split
globenewswire.com
ERNA
Ernexa Therapeutics Highlights Key Catalysts as Company Advances Toward First-in-Human Clinical Trials in 2026
globenewswire.com
ERNA
Form 8-K
sec.gov
ERNAW
ERNA
Form 8-K
sec.gov
ERNA
ERNAW
Ernexa Therapeutics to Participate in Virtual Investor Closing Bell Series
globenewswire.com
ERNA
Ernexa Therapeutics Announces Pricing of $10.5 Million Public Offering
globenewswire.com
ERNA
Ernexa Therapeutics Participates in Virtual Investor “What This Means” Segment Highlighting Recent Successful Pre-IND Meeting with U.S. FDA
globenewswire.com
ERNA
Ernexa Therapeutics Selected as One of Only Ten Global Companies for Prestigious JETRO Japan Entry Acceleration Program
globenewswire.com
ERNA